Genentech Starts Pulling Back Psoriasis Drug - NYTimes.com

Genentech Starts Pulling Back Psoriasis Drug - NYTimes.com: "Genentech announced on Wednesday a phased voluntary withdrawal of the psoriasis drug Raptiva from the United States because of a link to a brain infection.

Raptiva has been associated with an increased risk of progressive multifocal leukoencephalopathy, a rare and usually fatal disease of the central nervous system." [NYT]